ADARx Pharmaceuticals (Series B-1)
Funding Details
- Awarder
- Inbox
- Date Award
- January 20, 2023
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $46,000,000
Company Info
- Founders
- Dr. Zhen Li
- Company Description
- ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.
- Market
- RNA targeting therapeutics
- Location
- San Diego, CA, USA
- Coinvestors
- Ascenta Capital, Lilly Asia Ventures, OrbiMed Advisors, Sirona Capital, SR One